Company Valuation: Theracryf Plc

Data adjusted to current consolidation scope
Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 12.65 12.58 3.919 6.191 5.533 6.233 -
Change - -0.51% -68.86% 57.98% -10.62% 12.64% -
Enterprise Value (EV) 1 1.317 6.354 1.358 3.34 4.91 6.164 9.252
Change - 382.62% -78.63% 145.93% 47.01% 25.54% 50.11%
P/E -3.7x -2.51x -0.76x -0.6x -1.21x -1.92x -2.15x
PBR 1.09x 1.89x 0.96x 0.19x 1.5x - -
PEG - -0.1x 0x 0x 0x 0x 0.2x
Capitalization / Revenue - 22.9x 7.75x - - - -
EV / Revenue - 11.6x 2.68x - - - -
EV / EBITDA - - - - - - -
EV / EBIT -0.33x -1x -0.3x -1.16x -1x -1.71x -2.57x
EV / FCF - - - - - - -
FCF Yield - - - - - - -
Dividend per Share 2 - - - - - - -
Rate of return - - - - - - -
EPS 2 -0.0124 -0.0182 -0.0146 -0.00488 -0.00212 -0.00119 -0.00106
Distribution rate - - - - - - -
Net sales 1 - 0.5487 0.5059 - - - -
EBITDA -3.996 -6.32 -4.54 -2.574 -4.535 - -
EBIT 1 -4.016 -6.336 -4.555 -2.878 -4.892 -3.6 -3.6
Net income 1 -3.433 -5.019 -4.007 -2.63 -4.675 -2.955 -2.955
Net Debt 1 -11.33 -6.229 -2.561 -2.851 -0.6236 -0.0689 3.02
Reference price 2 0.046008 0.045774 0.011061 0.002907 0.002575 0.002281 0.002281
Nbr of stocks (in thousands) 274,888 274,888 354,288 2,129,622 2,148,964 2,732,297 -
Announcement Date 08/06/22 07/06/23 28/05/24 03/06/25 28/09/26 - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
-1.92x - - - 6.23M
16.47x6.17x11.83x1.81% 62.23B
29.48x7.92x26.5x0.05% 54.92B
37.71x6.69x19.98x0.86% 55.26B
33.73x3.23x13.93x-.--% 42.59B
47.65x5.47x29.98x-.--% 41.08B
-19.53x189.01x-20.8x-.--% 40.33B
44.75x7.99x26.76x-.--% 33.12B
32.06x8.14x21.19x0.4% 32.61B
-68.85x12.63x-70.58x-.--% 23.98B
Average 15.16x 27.47x 6.53x 0.35% 38.61B
Weighted average by Cap. 21.26x 25.92x 10.79x 0.46%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Theracryf Plc

Historical PBR trend

Valuation ratios - PBR - Theracryf Plc

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Theracryf Plc

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Theracryf Plc

  1. Stock Market
  2. Stocks
  3. EVG Stock
  4. Valuation Theracryf Plc